Development and validation of stability indicating RP-HPLC method for nebivolol by using the DOE approach
Background: Nebivolol (NBV), classified as a third-generation β1-adrenergic receptor antagonist, is commonly prescribed for managing hypertension. Accurate and prompt quantification of NBV in bulk materials and pharmaceutical formulations is crucial for quality assurance. This research focuses on de...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Creative Pharma Assent
2025-06-01
|
| سلاسل: | Journal of Applied Pharmaceutical Research |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://japtronline.com/index.php/joapr/article/view/1062 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|